Universities’ Collaboration in Immunology Research May Impact Diseases Such as IBD

Universities’ Collaboration in Immunology Research May Impact Diseases Such as IBD
University of California San Diego School of Medicine and Chiba University School of Medicine in Japan recently announced the creation of a collaborative research center for immunology research, with a special focus on the microbiome and its impact on human health and the development of diseases such as inflammatory bowel disease (IBD). The Chiba University-UC San Diego Immunology Initiative and associated research center will be established with a $2 million funding contribution from Chiba University to be allocated over five years, with the support of UC San Diego. The physiological balance of bacteria communities in the gut is essential to overall health and well-being, as the so-called “good” bacteria perform important physiological functions, such as the breakdown of food and nutrients, development of the immune system, and protection against disease-causing pathogenic bacteria. Microbiota imbalance has been shown to be involved in the development of IBD. Mucosal immune responses affect a wide range of other diseases, such as infection, allergy, asthma, arthritis, type 1 diabetes, multiple sclerosis, and cancer. As a result, there is a great need to find effective treatments to restore microbiome function, and these therapies would affect a great number of patients. The initiative will be co-directed by Prof. Peter Ernst, DVM, Ph.D., professor of pathology at UC San Diego School of Medicine, and Prof. Hiroshi Kiyono, DDS, Ph.D., University of Tokyo and Chiba University. Initial projects will focus on both medical and veterinary science, vaccine development, allergy, inflammation, infectious diseases, mucosal immunolog
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *